$327 Million is the total value of Alphabet Inc.'s 6 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARRS | Arris Group Inc New | $296,636,000 | +17.7% | 9,703,500 | 0.0% | 90.77% | +49.9% | |
| ONDK | Sell | On Deck Cap Inc | $27,644,000 | -21.1% | 2,683,853 | -24.1% | 8.46% | +0.5% |
| FIT | Fitbit Inc.cl a | $1,535,000 | -21.5% | 51,886 | 0.0% | 0.47% | 0.0% | |
| LC | Sell | LendingClub Corp | $517,000 | -99.6% | 46,832 | -99.5% | 0.16% | -99.5% |
| TWTR | Sell | Twitter Inc | $469,000 | -84.5% | 20,274 | -81.9% | 0.14% | -80.2% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPERO THERAPEUTICS INC | 24 | Q3 2023 | 3.5% |
| AUTOLUS THERAPEUTICS PLC | 22 | Q3 2023 | 2.8% |
| Magenta Therapeutics Inc. | 21 | Q2 2023 | 3.8% |
| DEXCOM INC | 20 | Q3 2023 | 17.4% |
| Evelo Biosciences Inc. | 20 | Q1 2023 | 1.6% |
| ALECTOR INC | 19 | Q3 2023 | 1.1% |
| Lyft Inc | 18 | Q2 2023 | 51.9% |
| QUINCE THERAPEUTICS INC | 18 | Q3 2023 | 0.6% |
| Arcus Biosciences Inc | 17 | Q1 2022 | 12.7% |
| FULCRUM THERAPEUTICS INC | 17 | Q3 2023 | 0.7% |
View Alphabet Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ARRIS International plc | February 14, 2019 | 7,603,500 | 4.4% |
View Alphabet Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| PX14A6G | 2024-05-08 |
| PX14A6G | 2024-05-07 |
| PX14A6G | 2024-05-06 |
| 13F-HR | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
| PX14A6G | 2024-05-02 |
| 144 | 2024-05-01 |
View Alphabet Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.